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Abstract Prolonged stress perturbs physiological balance of
a subject and thus can lead to depression. Nevertheless, some
individuals are more resilient to stress than the others.
Defining molecular factors underlying resilience to stress
may contribute to the development of a new antidepressant
strategy based on the restoration of resilient phenotype in de-
pressed subjects. We used chronic mild stress (CMS) para-
digm—well-characterized animal model of depression which
caused in rats behavioral deficits (anhedonia) manifested by
decreased consumption of sucrose solution. CMS also gener-
ated a proportion of resilient rats which did not alter sucrose
consumption despite being stressed. Recently, regulation of a
gene expression associated with microRNA (miRNA) is con-
sidered as an important factor modulating biochemical re-
sponse to stress. Based on our previous work and literature
survey, we investigated changes in the expression level of
seven miRNAs (i.e., miR-18a-5p, miR-34a-5p, miR-135a-
5p, miR-195-5p, miR-320-3p, miR-674-3p, miR-872-5p) in
mesocortical circuit—crucially involved in stress response in
order to find differences between susceptible and resilient
phenotype. Bioinformatic analysis showed that all miRNAs
of interest potentially target serotonin transporter (SERT).
Chronic stress caused global increase in the expression of
the abovementioned miRNAs in ventral tegmental area
(VTA) of stressed rats followed by parallel decrease in
miRNA expression in prefrontal cortex (PCx). This effect
was more profound in resilient than anhedonic animals.
Moreover, we observed decreased level of SERT in VTA of
resilient rats. Our findings show that mesocortical circuit is
involved in the response to stress and this phenomenon is
more efficient in resilient animals.
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Introduction
Stress is defined as conditions which perturb the psychologi-
cal and physiological balance of an individual. Exposure to
prolonged periods of stress can lead tomental illnesses such as
depression or anxiety. It has been established that some indi-
viduals are more resilient to stress than others, and these var-
iations in response to stress concern not only humans but also
mammals. It has been shown that susceptibility to stress as
well as resilience depends on a combination of genetic and
non-genetic factors which interact in complex ways [1].
However, molecular mechanisms underlying stress response
are not fully understood. Recently, epigenetic regulation of a
gene expression associated with action of small RNA tran-
scripts, named microRNA (miRNA), has come to be consid-
ered an important factor contributing to biochemical response
to stress in dynamic, complex, and pleiotropic manner [2].
miRNAs, widely expressed in eukaryotes, are small (17–24
nucleotides), non-coding RNA molecules which play impor-
tant role in posttranscriptional regulation of a diversity of
genes including brain-specific targets [3]. miRNAs mainly
bind to the three prime untranslated region (3′-UTR) of targeted
messenger RNA (mRNA) and, by recruitment of a protein
complex named RNA-induced silencing complex (RISC),
repress mRNA translation. [4, 5]. It is worth noting that
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animal miRNAs act throughout partial complementarity. A
short specific sequence consisting of seven nucleotides (from
positions 2 to 8) in 5′ end of miRNA molecule (named seed
region) defines miRNA specificity to targeted mRNA [5].
Therefore, one miRNA may regulate translation of more than
one protein, and one mRNAmay be targeted by many different
miRNAs. Their pleiotropic character of action as well as their
ubiquity makes miRNAs perfectly suited regulators of homeo-
static state during stress [6].
Recent studies have revealed that alterations of various
miRNAs in the brain as well as in peripheral tissues, such as
blood, may be associated with stress response [7, 8], schizo-
phrenia, depression [9], and/or treatment with antidepressant
drugs [10, 11]. Moreover, altered expressions of miR-18a,
miR-124, miR-343-3p, miR-16, miR-141, miR-182, and
miR-200a in the brain tissue of suicidal patients have been
reported [6].More recently, it has been reported that depressed
patients exhibit disturbed levels of miR-320 and miR-451 in
blood as compared to healthy controls [12]. Although much is
known on the role of miRNAs in pathology of mental illness,
knowledge about the role of miRNA molecules in the stress
resilience phenomenon is still rising. Issler et al. have shown
that miR-135a has been associated with stress resilience and
antidepressant treatment. The authors even postulate that miR-
135a may act as an endogenous antidepressant [13].
To further explore the issue concerning involvement of
miRNA action in response to stress, we used chronic mild
stress (CMS) paradigm, which is a well-considered animal
model of depression with good face, predictive and construct
validity [14]. Chronic exposure of rats to mild unpredictable
stressors causes behavioral deficits (anhedonia) which can be
reversed by chronic treatment with antidepressant drugs
[15–17]. Moreover, in CMS model, there is a proportion of
animals which demonstrates resilience to the stress regimen
which manifests as unaltered consumption of palatable su-
crose solution under stressful conditions [18, 19]. As such,
the CMS model seems to mimic natural variety in behavioral
response to stress observed among people since not all sub-
jects develop depression despite experiencing prolonged
stress. Previously, we have shown that stress-resilient animals
exhibited elevated level of miR-16 in serum together with
alterations in the expression level of miR-16 in the ventral
tegmental area (VTA) and prefrontal cortex (PCx) during dif-
ferent time points of the stress procedure [20]. These results
were interesting, as mesocortical and mesolimbic pathways
are strongly involved in stress response [21–23]. Moreover,
it has been shown that miR-16 negatively regulates the level
of serotonin transporter (SERT) in the brain [11]. Thus, it can
be postulated that biochemical response to stress, observed
especially among resilient subjects, may be regulated by
miRNA molecules. To test this hypothesis, in our present
study, we decided to look closer at the potential interplay
between behavioral stress responses and changes in the
expression level of a set of different miRNAs in mesocortical
circuit among susceptible and resilient animals and whether
these changes may accompany any common biochemical
marker associated with pathophysiology of depression.
Based on our previous study [20] and literature survey, we
chose a set of seven different miRNAs (i.e., miR-18a-5p,
miR-34a-5p, miR-135a-5p, miR-195-5p, miR-320-3p, miR-
674-3p, miR-872-5p) which are associated with stress re-
sponse and functioning of the central nervous system.
Materials and Methods
Chronic Mild Stress Procedure
Training period as well as CMS procedure was performed
according to the method described in detail by Zurawek
et al. [24]. In brief, male Wistar Han rats (Charles River,
Germany) were first trained to consume a palatable 1 % su-
crose solution for six consecutive weeks. During training time,
sucrose solution was presented to the rats (twice per week)
following overnight food and water deprivation. Sucrose con-
sumption was measured after each 1-h test by reweighing the
preweighed bottles containing the sucrose solution. Next, rats
(n = 220) were randomly divided into the control (n = 110)
and stressed (n = 110) groups. Control animals were housed
undisturbed in a separate roomwith water and food ad libitum
except deprivation time before the sucrose test. The stressed
group of animals was subjected to the weekly stress regimen
for two consecutive weeks. Each weekly stress regimen
consisted of two periods of food deprivation, 45° cage tilt,
intermittent illumination (lights on and off every 2 h), and
low-intensity stroboscopic illumination (150 flashes/min)
and one period of water deprivation, one soiled cage
(250 ml of water in the sawdust bedding), and paired housing.
All stressors lasted for 10–14 h. Sucrose intake was monitored
in all groups of rats once per week. Distinctions between an-
hedonic (n = 78) and resilient animals (n = 32) were made
based on the observation of behavior associated with sucrose
consumption of each animal. Particular stressed rat was de-
fined as anhedonic when during stress procedure, sucrose con-
sumption level decreased by more than 20 % as compared to
its baseline consumption level (before the start of the CMS)
and as compared to consumption observed in non-stressed
control group of animals. Resilient rat was defined when its
sucrose consumption did not decrease (or even sometimes
increased) as compared to its baseline sucrose consumption
level (and to consumption in control group of rats) despite the
fact that this animal was under stress influence. Then, differ-
ences in the sucrose consumption levels by the rats after CMS
procedure were retrospectively analyzed by using two-way
ANOVA relative to the median split of the baseline sucrose
consumption as well as to the control group of animals. For
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our further biochemical experiments, we randomly chose 14–
16 animals from each group after 2 weeks of CMS. The re-
maining animals were used for another experiment and were
not included in this study. All of the behavioral experiments
were performed in accordance with the guidelines of the eth-
ical use of animals set by the European Community Council
Directive and were approved by the Local Bioethics
Commission.
Serum and Brain Tissue Collection
Of tail vein blood, 0.5 ml was collected from each rat to the
Eppendorf tubes at the baseline (i.e., before the start of the
CMS paradigm) and after 1 week of CMS. At the end of
CMS procedure, trunk blood was collected. Blood samples
were kept at room temperature for 30 min to clot and then
centrifuged for 20min at 4 °C at 1500×g. After centrifugation,
serum was collected to new Eppendorf tubes. Potential occur-
rence of hemolysis was checked in all serum samples by using
NanoDrop spectrophotometer (Thermo Scientific, MA, USA)
at 414-nm wavelength absorbance which corresponds to he-
moglobin presence. Non-hemolyzed serum samples were fro-
zen and stored at −80 °C until further analysis.
Rats were sacrificed by decapitation, and brains were rap-
idly removed from the skull. Next, for autoradiographic and in
situ hybridization studies, whole rat brains were frozen by
using a heptane–dry ice mixture. Then, brains were cut ac-
cording to The Rat Brain in Stereotaxic Coordinates Atlas
(Paxinos and Watson 1998) into 12-μm-thick coronal brain
sections through prefrontal cortex (bregma, 3.70 to
1.70 mm), dorsal raphe nucleus (bregma, −7.30 to
8.8.00 mm), and ventral tegmental area (bregma, −5.80 to
−6.30 mm) by using a Jung CM 3000 cryostat microtome
(Leica, Germany). The slices were thaw mounted on
gelatine-covered microscope slides, air dried, and stored at
−20 °C until use (Fig. 1).
For RT-qPCR and HPLC studies, the remaining brains
were cut into 1-mm-thick coronal slices containing structures
of interest by using cutting edge. Then, ventral tegmental area
(bregma, −5.80 to −6.30 mm) and prefrontal cortex (bregma,
3.70 to 1.70mm) were punched out, by using a tissue puncher,
from tissue slices containing the above structures, according
to The Rat Brain in Stereotaxic Coordinates Atlas (Paxinos
and Watson 1998). All tissue samples were frozen on dry ice
in Eppendorf tubes and stored at −80 °C until use.
miRNA Purification from Serum and Brain Tissue
Samples
Total RNA including miRNA from serum and brain tissue
samples was purified by using miRNeasy Serum/Plasma Kit
(Qiagen, Germany) and miRNeasy Mini Kit (Qiagen,
Germany), respectively. All purification procedures were
performed according to attached protocols combined with
the use of a QIAcube robotic workstation (Qiagen,
Germany) for automated purification of total RNA including
miRNA. Synthetic ath-miR-159a miRNA mimic (Life
Technologies, CA, USA) was spiked into QIAzol Lysis
Reagent to a final concentration of 4 fmol/ml in order to con-
trol quality of the RNA purification, complementary DNA
(cDNA) synthesis, and PCR amplification in the qPCR exper-
iment. Purity and concentration of purified RNA samples
were measured with the use of NanoDrop spectrophotometer
(Thermo Scientific, MA, USA). Samples with good quality
were taken for further RT-qPCR analysis.
Real-Time qPCR Analysis of miRNA Expression
and Data Normalization
One microgram of total RNA from brain samples and 3 μl of
total RNA from serum samples were reverse transcribed into
cDNA by using the TaqMan® MicroRNA Reverse
Transcription Kit (Life Technologies, CA, USA) and
custom-made TaqMan® MicroRNA reverse transcription
primer pool (Life Technologies, CA, USA) according to the
procedure for mult iplexing the RT step without
preamplification while using TaqMan® MicroRNA Assays.
Custom-made TaqMan® MicroRNA RT pool consisted of a
mixture of 0.05× specific stem-looped RT primers for miR-
18a-5p, miR-34a-5p, miR-135a-5p, miR-195-5p, miR-320-
3p, miR-674-3p, miR-872-5p, ath-miR-159a-5p, miR-106b,
and let-7i (Life Technologies, CA, USA) dissolved in 1× TE
buffer (Sigma-Aldrich, Germany). This set of miRNAs was
selected based on our previous observations and literature
showing that miRNAs mentioned above may be associated
with stress response and functioning of the nervous system.
Then, 6 μl of cDNA from each sample was mixed with 50 μl
of TaqMan® Universal PCR Master Mix, No Amperase®
UNG (Life Technologies, CA, USA), and 44 μl of nuclease-
free water (Sigma-Aldrich, Germany) to a final volume of
100 μl. Then, the cDNA mixture was loaded into the
custom-made TaqMan® Low Density Cards (TLDA) (Life
Technologies, CA, USA). RT-qPCR reaction was run on the
QuantStudio™ 12K Flex system (Life Technologies, CA,
Fig. 1 Schematic representation of behavioral experiment and time
points in which blood and brain tissue samples were collected
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USA) by using the default thermal cycling conditions and the
automatic baseline and threshold values in accordance with
the manufacturer’s protocol. Raw Ct values were analyzed by
using qubasePLUS software (Biogazelle, Belgium). Ct values
were normalized by using the delta–delta Ct method and con-
verted to relative quantities for NormFinder and geNorm anal-
ysis. The relative quantities of target miRNAs were normal-
ized by using qubasePLUS software to the geometric means
of miR-106b and let-7i which showed stable expression and
thus meet the criteria of reference targets.
Bioinformatic Comparative Analysis of Prediction
of SERT–miRNA Interaction
We used miRWalk2.0—online available software and data-
base (http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2
/index.html)—which shows miRNA binding sites within the
complete sequence of rat genome (including 5′-UTR, 3′-UTR
regions as well as coding sequences) and combines this
information with a comparison analysis of binding sites
predicted by other existing miRNA target prediction
algorithms such as miRNAMap, RNAhybrid2.1, or
TargetScan6.2. We classified particular miRNA as potential
SERT mRNA regulator if any of the abovementioned
miRNA target prediction algorithms (included in
comparison analysis provided by miRWalk2.0) revealed
miRNA–SERT interaction. The list of miRNAs potentially
involved in SERT posttranscriptional regulation together
with algorithms that documented this interaction is shown in
Table 1.
[3H]Paroxetine Binding to Serotonin Transporter
and Analysis of Autoradiograms
Tissue sections were preincubated in 50 mM Tris–HCl buffer
(pH 7.4) with 300 mM NaCl at room temperature for 15 min.
Then, the brain slices were incubated for 90 min at room
temperature in 50 mM Tris–HCl (pH 7.4) incubation buffer
containing 300 mM NaCl and 1 nM [3H]paroxetine (specific
activity 15.5 Ci/mmol). Non-specific binding was determined
by using 10 μM fluoxetine. After incubation, tissue sections
were washed 2 × 2 h in 50 mM Tris–HCl buffer (pH 7.4) with
300 mMNaCl at 4 °C and once in ice-cold distilled water. The
sections were dried overnight under a stream of air. The la-
beled with [3H]paroxetine brain slices were placed against an
imaging plate (Fujifilm, Japan) with autoradiographic micro-
scales (GE Healthcare) for 7 days. After this time, plates were
developed by using FujiFilm BAS-5000 Phosphoimager
(FujiFilm, Japan). The obtained autoradiograms were ana-
lyzed and quantified by using ImageGauge software
(Fujifilm, Japan). The specific binding of radioligand was cal-
culated by subtracting non-specific binding images in adjacent
brain slices from the total binding signal. The results are
expressed in femtomole of bound radioligand per milligram
of tissue (fmol/mg) in each examined structure.
SERT mRNA In Situ Hybridization
Brain tissue coronal slices were fixed in 4 % formaldehyde for
10 min on ice, washed in ice-cold PBS buffer for 5 min, and
then incubated for 10 min in an ice-cold acetic anhydride
(0.25 %)—TEA (0.1M) solution. Fixed brain slices were then
dehydrated in ethanol and subjected to two 10-min incuba-
tions in chloroform. Next, slices were washed again in ethanol
and air dried. A mixture of three commercially available oli-
gonucleotides complementary to the rat SERT mRNA was
used in the in situ hybridization assay. SERT oligonucleotide
probe sequences were as follows:
5′GCATCTACCCACACCCCTGTCTCCAAGAGTTT
CTGCCAGTTGGG3′; 5′ACGATGAGCACGAACCATTC
CCTGCGCTTGGCCCAGATGTGA3′; 5′ATCCGCTC
CTTAAGTGTCCCCGGAGTGCTGATCAGCCGATAAAT
G3′.
Oligonucleotide probes were labeled at the 3′ end with
[35S]dADP (Hartmann Analytic, Germany) by using terminal
transferase (Fermentas, Lithuania). The probes were
suspended to a final concentration of 1 pmol per 200 μl of
hybridization buffer containing the following components: 1×
Denhardt’s solution (0.02 % polyvinylpyrrolidone/0.02 %
Ficoll/0.02% bovine serum albumin), 4× saline sodium citrate
(SSC) (pH 7.0), 50 % (v/v) formamide, 10 % (w/v) dextran
sulfate, yeast tRNA (0.25 mg/ml), salmon sperm ssDNA
(0.2 mg/ml), and 10 mM dithiotreitol. Tissue slices were in-
cubated with hybridization buffer containing radiolabeled
probes for 18 h at 37 °C in humid conditions then washed
four times (15 min each) in 2× SSC with 50 % formamide at
42 °C. The hybridized brain sections were rinsed with distilled
water, dehydrated in ethanol, and air dried. Prepared tissue
sections were placed into X-ray cassettes and exposed to film
plates (Kodak) for 90 days at a temperature of −20 °C. The
Table 1 List of miRNAs of interest which showed potential interaction
with SERT based on miRWalk2.0 comparison analysis of binding sites
predicted by four different algorithms
Gene miRNA miRWalk RNAhybrid miRMap TargetScan
slc6a4 miR-18a-5p 1
slc6a4 miR-34a-5p 1 1
slc6a4 miR-135a-5p 1 1 1 1
slc6a4 miR-195-5p 1 1 1 1
slc6a4 miR-320-3p 1 1
slc6a4 miR-674-3p 1 1
slc6a4 miR-872-5p 1
1 means positive interaction revealed by a particular algorithm
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developed autoradiograms were analyzed, quantified, and
normalized by using ImageGauge software (Fujifilm, Japan).
Data are expressed as percent changes in mRNA signals com-
pared with the control group (expressed as 100 %).
Statistical Analysis
The effect of 2 weeks of CMS on sucrose consumption and
time-dependent changes in serum levels of miRNAs were
analyzed by using two-way ANOVA followed by
Bonferroni’s post hoc test. p values from analysis of time-
dependent changes in serum miRNAs were also corrected
for multiple comparisons by using the correction method of
Benjamini and Hochberg, controlling the false discovery rate
(FDR) at an alpha level of 5 % [25]. One-way ANOVA anal-
ysis of variances followed by Tukey’s multiple comparison
post hoc test was used to analyze changes in the expression
level of miRNAs, changes in [3H]paroxetine binding to SERT,
and changes in SERTmRNA expression in rat brain structures
after 2 weeks of CMS. Statistical analysis of the data was
performed by using GraphPad Prism5 software (GraphPad
Software, Inc., La Jolla, CA, USA).
Results
The Effect of 2 Weeks of the CMS Procedure on Sucrose
Consumption
After 2 weeks of the CMS procedure, repeated measures
ANOVA revealed statistically significant effect of stress
(F2,129 = 72.42; p < 0.0001), time (F2,129 = 14.57;
p < 0.0001), and interaction stress × time (F4,129 = 26.57;
p < 0.0001) on the consumption of a palatable sucrose solution
by the rats (Fig. 2). Additionally, Tukey’s post hoc test showed
that anhedonic group of rats after first week of CMS procedure
significantly decreased sucrose consumption as compared to
non-stressed and resilient groups of rats. This effect was main-
tained during the second week of the stress regimen. On the
other hand, resilient group of animals despite being stressed
did not change their sucrose consumption during CMS as
compared to baseline level of sucrose consumption before
the stress and as compared to control group of rats.
The Effect of 2 Weeks of CMS on the Expression Levels
of miR-18a-5p, miR-34a-5p, miR-135a-5p, miR-195-5p,
miR-320-3p, miR-674-3p, and miR-872-5p
in Mesocortical Pathway
Our results clearly show that exposure to 2 weeks of
CMS st rong ly affec ted miRNA express ion in
mesocortical pathway (Fig. 3). One-way ANOVA re-
vealed increased expression levels of all miRNAs of
interest (except miR-135a-5p, see Fig. 3c) after 2 weeks
of CMS in VTA (Fig. 4a, b, d–g) of stressed animals as
compared to non-stressed group of rats (miR-18a-5p
F2,29 = 4.34, p < 0.05; miR-34a-5p F2,29 = 8.03,
p < 0.01; miR-195-5p F2,29 = 12.88, p < 0.001; miR-
320-3p F2 ,29 = 11.31, p < 0.001; miR-674-3p
F2,29 = 19.99, p < 0.0001; miR-872-5p F2,29 = 18.18,
p < 0.0001). This effect was even more profound
among resilient group of animals as compared to control
Fig. 2 The effect of chronic unpredictable stress exposure on 1 %
sucrose solution consumption [g] in control, anhedonic, and resilient
animals. Time points from −6 to 0 represents consecutive sucrose testes
of all animals during adaptation period. Adaptation represents time when
animals were trained to drink 1 % sucrose solution. Time point 0 named
Bbaseline^ represents the last sucrose test before the start of the weekly
stress regimen. After initiation of stress, anhedonic rats (after first week of
stress) significantly decreased their sucrose consumption as compared to
their basal sucrose consumption as well as to non-stressed controls and
resilient animals which, in turn, despite being stressed did not change
their sucrose consumption as compared to their baseline sucrose
consumption and controls. Results were retrospectively analyzed by
using repeated measures ANOVA followed by Bonferroni’s post hoc test.
n = 14–16; ****p < 0.0001
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and anhedonic rats as showed by post hoc analysis
(Fig. 3a, b, d, e, g). Moreover, statistical analysis
showed that stress exposure for two consecutive weeks
also decreased the expression levels of all examined
miRNAs (except miR-34a-5p, see Fig. 3b) in rat PCx
(Fig. 3a, c–f) as compared to control group of rats
(miR-18a-5p F2,29 = 14.19, p < 0.0001; miR-135a-5p
F2,29 = 16.95, p < 0.0001; miR-195-5p F2,29 = 4.13,
p < 0.02; miR-320-3p F2,29 = 10.57, p < 0.001; miR-
674-3p F 2 , 2 9 = 4 .03 , p < 0 .05 ; miR-872-5p
F2,29 = 15.67, p < 0001). Again, post hoc analysis
revealed that impact of stress on the expression level
of different miRNAs was greater in resilient group of
rats as compared to control and anhedonic animals
(Fig. 3d–g).
Dynamic Changes in the Serum Levels of miR-18a-5p,
miR-34a-5p, miR-135a-5p, miR-195-5p, miR-320-3p,
miR-674-3p, and miR-872-5p during 2 Weeks of the CMS
Procedure
We analyzed time-dependent changes in serum levels of seven
miRNAs which have a potential to interact with SERT (see
Table 1) in order to find whether peripheral and dynamic
changes in the levels of miRNAs mentioned above may be
associated with behavioral state of the animals. miR-135a-5p
was not detectable in rat serum. The rest of the six miRNAs
were present in serum. At the Bbaseline^ time point (i.e., be-
fore the start of the stress procedure), all animals exhibited
similar levels of all assayed miRNAs (Fig. 4). Two-way
ANOVA analysis of variances showed significant effect of
Fig. 3 The influence of 2 weeks of CMS on the expression level of a set
of seven miRNAs in mesocortical circuit of control (C), anhedonic (A),
and resilient animals (R). Left panel of each graph represents particular
expression in ventral tegmental area (VTA), and right panel represents
results from miRNA expression in prefrontal cortex (PCx). miRNA
expression represented as relative quantity with regard to control
analyzed by one-way ANOVA followed by Tukey’s post hoc test.
n = 10; *p < 0.05, **p < 0.01, ***p < 0.001
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time (F2,54 = 5.81; p < 0.01) and interaction stress × time
(F4,54 = 3.86; p < 0.01) on the serum level of miR-34a-5p
(Fig. 4b). Tukey’s post hoc analysis together with the correc-
tion of the p values for multiple comparisons showed that
serum level of miR-34a-5p was significantly elevated after
2 weeks of CMS in resilient group of animals as compared
to control and anhedonic rats (Fig. 4b).
The Effect of Stress Exposure on the Expression Level
of SERT Protein in Mesocortical Circuit and the Level
of mRNA Encoding SERT in Dorsal Raphe Nucleus
We examined the binding of [3H]paroxetine (selective seroto-
nin reuptake inhibitor (SSRI)) to SERT in order to check
whether global changes in expression levels of different
miRNAs potentially targeting SERT may be associated with
altered SERT protein level in vivo in mesocortical circuit.
There was no difference in the SERT level in dorsal raphe
nucleus (DRN) and PCx of animals after 2 weeks of CMS
(Fig. 5d, f). Nevertheless, [3H]paroxetine binding to SERT
protein showed decreased level of SERT in VTA
(F2,11 = 9.15, p < 0.01) of resilient rats after 2 weeks of
CMS as compared to control and anhedonic groups of animals
(Fig. 5e).
In situ hybridization analysis showed no difference in the
level of mRNA encoding SERT in DRN in animals after
2 weeks of CMS (Fig. 5h).
Discussion
Coping strategies exhibited by an organism in the face
of stress are essential to minimize its negative impact.
Depression may result from insufficient adaptation of
the brain to adverse environmental stimuli. miRNAs
have a potential to regulate allostasis of the brain in
the face of stress and may contribute to develop the
depression through acting on major signaling pathways
induced by stress in different brain circuits [6]. It is
becoming clear that miRNAs are involved in the control
and maintenance of normal physiological functioning of
the central nervous system [3, 5]. Animal models of
depression which can discriminate susceptible from re-
silient subjects are of prime importance in order to fully
understand complex mechanisms underlying allostatic
balance in the face of stress. Moreover, the examination
of the differences between subjects susceptible and re-
silient to stress may give rise to the development of a
new, promising treatment of depression, based on the
restoration of resilient phenotypes among depressed in-
dividuals. In our present study, we used CMS—the
aforementioned animal model of depression. In CMS,
mild and chronic stressors are used in order to mimic
natural psychosocial stress often disturbing people with-
out being related to trauma. Moreover, importantly, the
CMS model (with the exception of anhedonic rats) dis-
criminates resilient animals which, despite being
Fig. 4 Time-dependent analysis of serum level of different miRNAs in
control, anhedonic, and resilient animals during 2 weeks of CMS. Serum
level of miR-135a-5p was undetectable. Baseline time point represents
miRNA serum level in rats before the start of the stress regimen. Two-way
ANONA followed byBonferroni’s post hoc test revealed increased serum
level of miR-34a-5p in resilient animals after 2 weeks of CMS as com-
pared to control and anhedonic rats. n = 5–9; **p < 0.01 vs control,
#p < 0.05 vs anhedonic
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stressed, maintain normal behavior. Although CMS is an
expensive, time-consuming animal model, it is well suit-
ed for experiments related to a natural and differential
stress response.
RNA interference, initiated in mammals mainly bymiRNA
molecules, is considered to be a new and upstream biochem-
ical level of posttranscriptional regulation of gene expression
importantly involved in buffering changes in response to
stress and thus allostatic balance. It is very likely that a natural
variety in miRNA expression among different subjects may
contribute to individual reaction to stress [26]. Defining
miRNA expression pattern in different brain circuits, as well
as in peripheral tissues, may lead to the molecular
characterization of resilient and susceptible phenotypes. In
the present study, we focused on a set of sevenmiRNAswhich
are potentially involved in stress response and pathophysiol-
ogy of depression.
Uchida et al. have shown that stress-vulnerable F344 rats
exhibited increased expression level of miR-18a-5p in the
hypothalamic paraventricular nucleus as compared to
Sprague–Dawley animals [27]. Moreover, they have also
shown that miR-18a-5p regulated the expression of glucocor-
ticoid receptor [27]. miR-34a-5p is important in regulating the
behavioral and neurochemical response to acute stress [8] and
modulates neurogenesis and synaptogenesis [28]. miR-135a-
5p has been shown to mediate anxiety-like and depression-
DRN VTA PCxa b c
d e
g
h
f
Fig. 5 Representative autoradiorgams of specific [3H]paroxetine binding
to SERT protein in DRN (a), VTA (b), and PCx (c) and SERTmRNA (g)
in coronal sections of the rat brain. Brain structures were dissected
according to Paxinos and Watson (1998). The effect of stress response
on SERT level was investigated in DRN (d), VTA (e), and PCx (f). h
SERT mRNA expression in DRN. One-way ANOVA analysis followed
by Tukey’s post hoc test showed significant decrease in [3H]paroxetine
binding to SERT protein in VTA of resilient animals as compared to
control and anhedonic rats (e). n = 4–6; *p < 0.05 vs anhedonic,
**p < 0.01 vs control
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like behaviors as well as antidepressant response [13]. miR-
195-5p regulates serotonergic signaling and BDNF level—
two biochemical pathways strongly involved in pathophysiol-
ogy of mental illness [29]. Decreased plasma level of miR-
320-3p has been observed in depressed and drug-naïve pa-
tients [12]. miR-674-3p and miR-872-5p have been shown
to be associated with traumatic stress response [30].
Moreover, our bioinformatic comparative analysis by using
miRWalk2.0 [31] which is an online freely accessible software
showed that all abovementioned miRNAs have a potential to
regulate SERT expression (see Table 1). SERT is one of the
main targets of commonly used antidepressant drugs. Our
previous results have revealed that the action of miR-16 in
the mesocortical circuit may be associated with resilient phe-
notype [20].
Mesocortical circuit consists of VTA—a midbrain struc-
ture, conserved among higher ordered vertebrates, which pro-
jects neuronal connections to PCx and limbic structures.
Dysregulation of a balance of mesocortical pathway under
stress is responsible for cognitive aspects of depression such
as impaired executive functioning [22]. Aversive as well as
reward-related stimuli can cause rapid excitement of VTA
neurons [32] which, in turn, change the functioning of PCx.
Moreover, it has been shown that dopaminergic mediation in
VTA is associated with a consumption of a palatable solution
and lesions to the VTA selectively disturbed overconsumption
of highly preferred solutions by the rats [33]. Additionally,
Martinez-Hernandez et al. have shown that lesions of VTA
reduced preference for sucrose in CD-1 female mice [34].
Smalhe i se r and co -worker s have shown tha t
antidepressant-free suicidal patients exhibited widespread de-
crease of miRNA expression in PCx as compared to matched
healthy controls [35]. Our results showed that anhedonic an-
imals exhibited decreased expression of two miRNAs poten-
tially involved in negative regulation of SERT (miR-18a-5p
and miR-135a-5p) in PCx as compared to non-stressed ani-
mals. Moreover, for the first time, we revealed that resilient
animals exhibited decreased expression levels of almost all
examined (except miR-34a-5p) miRNAs in PCx as compared
to the control group of rats. Although there was no statistically
significant effect of stress on miR-34a-5p expression level in
PCx, resilient animals exhibited trend to have decreased level
of this miR. It is noteworthy that resilient animals exhibited
higher degree of decrease in the expression level of miRNAs
of interest than anhedonic animals as compared to the control
group of rats. In case of miR-320-5p and miR-872-5p in PCx,
we observed that resilient animals were even more reactive to
stress than anhedonic-like rats that was reflected by statistical-
ly significant change in the expression of both mentioned
above miRNAs in resilient animals as compared to
anhedonic-like group of rats. Decreased miRNA expression
in PCx may result from hypo-activation of this structure in
animals and, as shown by Smalheiser et al., human
experiencing prolonged stressful conditions. Nevertheless,
hypo-activation of PCx under stress at the level of miRNA
biogenesis seems not to be sufficient to induce depressive
symptoms as we showed that it occurs both among susceptible
and resilient animals. This phenomenon may be a natural re-
action to stress observed in both groups of animals and human
and may be caused by negative feedback from other structures
functionally connected to PCx such as VTA which projects
directly to PCx creating mesocortical circuit. In our study, we
observed an interesting relationship: Decrease in miRNA ex-
pression in PCx of stressed animals was accompanied by an
increase in miRNA expression in VTA; however, it should be
noted that we observed a lack of effect of miR-135a-5p in
VTA, and this observation needs further investigation.
Again, resilient animals exhibited more profound increase in
miRNA expression in VTA than anhedonic rats as compared
to non-stressed control group of rats (see Fig. 3). Our obser-
vation shows that mesocortical circuit is involved in maintain-
ing allostatic balance under stress at the level of miRNA ex-
pression and it is more prevalent and dynamic in resilient than
anhedonic subjects. Thus, we can conclude that resilient ani-
mals exhibited more effective coping strategy in the face of
stress which was associated with more increased response in
miRNA expression in mesocortical system among resilient
animals as compared to both control and susceptible rats.
Although brain studies are more invasive and difficult to
perform than when using tests of peripheral tissues (such as
blood), they are still the most relevant, in order to explore the
molecular basis of mental illness. Nevertheless, research
aimed at finding peripheral markers reflecting changes asso-
ciated with mental illness are equally important. Recent ad-
vances have revealed that miRNAsmay be good candidates to
act as a peripheral marker of stress response [7, 13, 36].
Katsuura, for example, and co-workers have shown that nat-
uralistic stress in healthy students caused significant elevation
of miR-144/144* and miR-16 in blood [37]. Additionally, it
has been observed that resilient animals in CMSmodel exhibit
elevated and time-dependent level of miR-16 in serum [20].
Sun et al. have shown that expression levels of miR-34c-5p
and 34b-5p were significantly higher in peripheral blood leu-
kocytes of depressed patients than healthy controls. Moreover,
they have shown that suicide idea patients exhibited lower
levels of miR-34b-5p and miR-369-3p [38]. In our study, we
observed that resilient animals had increased serum level of
miR-34a-5p as compared to non-stressed and anhedonic rats.
This observation suggests that altered serum miRNA level
may be one of the markers reflecting efficient coping strate-
gies, without necessarily serving as a factor for determining
resilient phenotype because basal level of miR-34a-5p was
similar among all animals (see Fig. 3b). It is noteworthy that
miR-34a-5p, miR-34b-5p, and miR-34c-5p are members of
the same miRNA family, possessing identical seed region
and therefore similar potential targets. Among all miRNAs
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tested in our study, only serum level of miR-34a-5p was al-
tered after 2 weeks of CMS. It supports the hypothesis that
miRNAs belonging to miR-34-5p/449-5p family may have
the potential to be a peripheral marker of stress response es-
pecially since miR-34a-5p has been considered as specific for
brain and spinal cord tissue [39]. However, further studies are
needed to define the exact role of miR-34-5p/449-5p family in
stress-related pathologies because it has been shown that both
resilient animals and depressed patients exhibit increased
miR-34 levels.
Recent data suggest that miRNAs play an important role in
cellular response to stress as well as antidepressant action by
regulating the serotonergic system [40–42]. It is also con-
firmed that VTA receives rich serotonergic input from dorsal
and medial raphe nuclei [43]. This suggests that serotonin
signaling can coordinate VTA functioning which, in turn,
may influence on behavior related to reward. Our bioinformat-
ic analysis has shown that all miRNAs tested in our study have
a potential to regulate SERT level. Thus, we focused on SERT
changes in mesocortical circuit which may be associated with
miRNA alterations. We observed that there was no difference
in SERT level in all assayed structures between anhedonic and
control animals in CMS model, which is consistent with
Little’s research showing that there was no significant differ-
ence in [125I]RTI-55 binding to SERT in VTA between de-
pressed subjects and controls [44]. However, we have re-
vealed that resilient animals exhibited significantly de-
creased SERT protein level in VTA as compared to anhe-
donic and control rats (see Fig. 5) and this alteration ac-
companied increased expression in miRNAs which are
involved in negative regulation of SERT. Additionally,
in situ hybridization analysis showed no difference in
SERT mRNA level in DRG in all tested animals which
supports the hypothesis that SERT is engaged in response
to stress and is regulated by miRNAs in VTA. This effect
may reflect compensatory attempts taken by an organism
in the face of a challenging condition. Unfortunately, due
to technical limitations, we could not perform RT-qPCR
analysis of changes in miRNA expression levels in DRG,
and this needs further study.
Our findings show that mesocortical circuit is involved in
stress response and this phenomenon is more efficient in re-
silient animals. This response is shown at the level of miRNA
expression which, in turn, influenced downstream biochemi-
cal pathway associated with SERT expression. It also opens,
together with recent advances, new investigative avenue in
studies on the pathophysiology of mental illness at the level
of miRNA regulation.
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